BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36103642)

  • 21. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.
    Shen LJ; Wang SY; Xie GF; Zeng Q; Chen C; Dong AN; Huang ZM; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2015 Aug; 34(10):450-8. PubMed ID: 26264052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of neoplastic spread in colorectal cancer: implications for surveillance CT studies.
    Giess CS; Schwartz LH; Bach AM; Gollub MJ; Panicek DM
    AJR Am J Roentgenol; 1998 Apr; 170(4):987-91. PubMed ID: 9530048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicted outcomes of subdividing M1-stage metastatic lung cancer based on the prognosis and the response to local consolidative therapy.
    Wang F; Gao J; Ren Y; Su H; She Y; Xie D; Chen C
    Ann Transl Med; 2021 Aug; 9(16):1293. PubMed ID: 34532430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale.
    Tay SB; Low GH; Wong GJE; Tey HJ; Leong FL; Li C; Chua MLK; Tan DSW; Thng CH; Tan IBH; Tan RSYC
    JCO Clin Cancer Inform; 2024 May; 8():e2300122. PubMed ID: 38788166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classification.
    Shida D; Boku N; Nakamura Y; Yoshida T; Tanabe T; Yasui K; Takashima A; Kanemitsu Y
    Cancer Med; 2021 Oct; 10(20):6937-6946. PubMed ID: 34587374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and survival analysis of 837 Chinese colorectal cancer patients.
    Yuan Y; Li MD; Hu HG; Dong CX; Chen JQ; Li XF; Li JJ; Shen H
    World J Gastroenterol; 2013 May; 19(17):2650-9. PubMed ID: 23674872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
    Tufman A; Kahnert K; Kauffmann-Guerrero D; Manapov F; Milger K; Müller-Lisse U; Winter H; Huber RM; Schneider C
    Strahlenther Onkol; 2017 May; 193(5):392-401. PubMed ID: 28246699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes.
    Wang LP; Wang HY; Cao R; Zhu C; Wu XZ
    World J Surg; 2013 May; 37(5):1094-102. PubMed ID: 23385643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
    Chan SK; O'Sullivan B; Huang SH; Chau TC; Lam KO; Chan SY; Tong CC; Vardhanabhuti V; Kwong DL; Ng CY; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between preoperative CT scan and lung metastases according to surgical approach in patients with colorectal cancer.
    Hernández J; Molins L; Fibla JJ; Guirao Á; Rivas JJ; Casas L; Pajuelo N; Embún R;
    Cir Esp (Engl Ed); 2022 Mar; 100(3):140-148. PubMed ID: 35302934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
    Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
    World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?
    Song YX; Gao P; Wang ZN; Liang JW; Sun Z; Wang MX; Dong YL; Wang XF; Xu HM
    PLoS One; 2012; 7(3):e34087. PubMed ID: 22461900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas.
    Lin M; Yang Q; You R; Zou X; Duan CY; Liu YP; Huang PY; Xie YL; Wang ZQ; Liu T; Chen SY; Hua YJ; Chen MY
    Oral Oncol; 2021 Apr; 115():105200. PubMed ID: 33610003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
    van den Broek J; Geenen R; Heijnen L; Kobus C; Schreurs H
    Ann Surg Oncol; 2018 Jul; 25(7):1986-1991. PubMed ID: 29761333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.
    Nieder C; Hintz M; Oehlke O; Bilger A; Grosu AL
    Clin Transl Oncol; 2017 Sep; 19(9):1141-1146. PubMed ID: 28357633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging Lung Cancer: Metastasis.
    Shroff GS; Viswanathan C; Carter BW; Benveniste MF; Truong MT; Sabloff BS
    Radiol Clin North Am; 2018 May; 56(3):411-418. PubMed ID: 29622076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
    Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection.
    Chen YJ; Yeh ST; Kao PS; Ou LH; Lin CS
    World J Surg Oncol; 2020 May; 18(1):97. PubMed ID: 32418536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.